Log on / register
Feedback | Support | My details

Comments

Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective study

Agnès Meybeck email, Jean-Damien Ricard email, Guilène Barnaud email, Mathieu Eveillard email, Guillaume Chevrel email, Roman Mounier email and Didier Dreyfuss email

BMC Infectious Diseases 2008, 8:67doi:10.1186/1471-2334-8-67

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.